Optimal treatment of multivessel complex coronary artery disease

Haihui Sun1, Lianqun Cui2

  • 1Department of Cardiology, The Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China ; Department of Cardiology, The Central Hospital of Tai'an, Tai'an, Shandong 271000, P.R. China.

Insights

For multivessel complex coronary artery disease (MCCAD), single complete revascularization (CR) resulted in fewer cardiac events and lower medical costs over three years compared to fractionated or partial revascularization.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Economics

Background:

  • Multivessel complex coronary artery disease (MCCAD) poses significant challenges in treatment selection.
  • Optimizing revascularization strategies is crucial for improving patient outcomes and managing healthcare costs.

Purpose of the Study:

  • To compare major cardiac events and medical costs among MCCAD patients undergoing different revascularization strategies.
  • To identify the optimal and most economical treatment program for MCCAD.

Main Methods:

  • A retrospective study of 2,309 MCCAD patients treated over a decade.
  • Patients were categorized into single complete revascularization (CR), fractionated revascularization (FR), or partial revascularization (PR) groups.
  • Three-year follow-up assessed major cardiac events and associated medical costs.

Main Results:

  • The CR group had a significantly lower three-year cardiac event rate (17%) compared to FR and PR groups.
  • Average three-year medical costs were significantly lower in the CR group (62,100 RMB) than in the FR and PR groups.
  • Single CR demonstrated superior clinical and economic benefits.

Conclusions:

  • Single complete revascularization is the optimal treatment strategy for MCCAD patients when feasible.
  • CR offers a more cost-effective approach, reducing both cardiac events and healthcare expenditure.
  • This study highlights the importance of CR in managing complex coronary artery disease.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
723
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
487
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888